Gender Male
LinkedIn View on LinkedIn
Dan is Chief Scientific Officer at UNITY, leading the Company’s effort to create novel senolytic molecules for the treatment of diseases of aging. Prior to UNITY, Dan was Vice President and Head of Medicinal Chemistry at Theravance Biopharma, where he led the chemistry department to leverage Theravance’s multivalent approach to drug discovery. He
was a scientific leader within Research Leadership Team when the Theravance research group progressed six molecules into clinical development.
